Browse EV MemProt Atlas
- Frequency:
- literature support frequency.
- EVMP score:
annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| AN13A | Q8IZ07 | Ankyrin repeat domain-containing protein 13A (Protein KE03) | Predicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediation | 1 | 0.50 | ||||
| ANK2 | Q01484 | Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin) | Disease related genesHuman disease related genesPlasma proteinsPotential drug targetsPredicted intracellular proteinsTransporters | Fusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| ANKL2 | Q86XL3 | Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4) | Disease related genesEssential proteinsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteins | 1 | Receptor-signaling mediation | 1 | 0.50 | |||
| ANO1 | Q5XXA6 | Anoctamin-1 (Discovered on gastrointestinal stromal tumors protein 1) (Oral cancer overexpressed protein 2) (Transmembrane protein 16A) (Tumor-amplified and overexpressed sequence 2) | Disease related genesFDA approved drug targetsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 10 | Clinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| APC | P25054 | Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5) | Cancer-related genesDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteins | Clinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| AQP1 | P29972 | Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Channel-like integral membrane protein of 28 kDa) (Urine water channel) | Blood group antigen proteinsMetabolic proteinsPredicted membrane proteinsTransporters | 6 | Lips/oral mucosa miscellaneous disorder | Clinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||
| AQP10 | Q96PS8 | Aquaporin-10 (AQP-10) (Aquaglyceroporin-10) (Small intestine aquaporin) | Metabolic proteinsPredicted membrane proteinsTransporters | 6 | Fusion and delivery mediation | 1 | 0.50 | |||
| AQP11 | Q8NBQ7 | Aquaporin-11 (AQP-11) | 6 | Fusion and delivery mediation | 1 | 0.50 | ||||
| AQP4 | P55087 | Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4) | Human disease related genesMetabolic proteinsPredicted membrane proteinsTransporters | 6 | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| ARH40 | Q8TER5 | Rho guanine nucleotide exchange factor 40 (Protein SOLO) (Scambio) (Sabi) | Predicted intracellular proteins | Immune mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| ARHGB | O15085 | Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF) | Predicted intracellular proteins | Receptor-signaling mediation | 1 | 0.50 | ||||
| ASGR2 | P07307 | Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (C-type lectin domain family 4 member H2) (Hepatic lectin H2) (HL-2) | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| ASIC1 | P78348 | Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) | 2 | Heart failurePain | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| ASTRB | Q3KR37 | Protein Aster-B (GRAM domain-containing protein 1B) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 1 | Fusion and delivery mediation | 1 | 0.50 | |||
| ASTRC | Q8IYS0 | Protein Aster-C (GRAM domain-containing protein 1C) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 1 | Fusion and delivery mediation | 1 | 0.50 | |||
| AT10D | Q9P241 | Phospholipid-transporting ATPase VD (EC 7.6.2.1) (ATPase class V type 10D) (P4-ATPase flippase complex alpha subunit ATP10D) | EnzymesPredicted membrane proteinsTransporters | 10 | Fusion and delivery mediation | 1 | 0.50 | |||
| AT1A1 | P05023 | Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1) | Cancer-related genesDisease related genesEnzymesEssential proteinsFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted membrane proteinsTransporters | 10 | Cardiac arrhythmiaChronic obstructive pulmonary diseaseCorneal diseaseHeart failureHyperhidrosisMalariaSolid tumour/cancerSupraventricular tachyarrhythmiaMiddle East Respiratory Syndrome | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| AT2A2 | P16615 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) | Disease related genesEnzymesEssential proteinsFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 10 | AsthmaHeart failureHypertension | Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||
| AT2B1 | P20020 | Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1) | Disease related genesEnzymesFDA approved drug targetsMetabolic proteinsPlasma proteinsPredicted membrane proteinsTransporters | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | |||
| AT2B3 | Q16720 | Plasma membrane calcium-transporting ATPase 3 (PMCA3) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3) | Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | |||
| AT2C2 | O75185 | Calcium-transporting ATPase type 2C member 2 (ATPase 2C2) (EC 7.2.2.10) (Ca(2+)/Mn(2+)-ATPase 2C2) (Secretory pathway Ca(2+)-transporting ATPase type 2) (SPCA2) | EnzymesFDA approved drug targetsMetabolic proteinsPredicted membrane proteinsTransporters | 10 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| AT8A2 | Q9NTI2 | Phospholipid-transporting ATPase IB (EC 7.6.2.1) (ATPase class I type 8A member 2) (ML-1) (P4-ATPase flippase complex alpha subunit ATP8A2) | Disease related genesEnzymesHuman disease related genesPotential drug targetsPredicted membrane proteins | 10 | Fusion and delivery mediation | 1 | 0.50 | |||
| AT8B1 | O43520 | Phospholipid-transporting ATPase IC (EC 7.6.2.1) (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1) | Disease related genesEnzymesHuman disease related genesMetabolic proteinsPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 10 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| B3GT2 | O43825 | Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2) | 1 | Metabolism mediation | 1 | 0.50 | ||||
| BAIP2 | Q9UQB8 | BAR/IMD domain-containing adapter protein 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2) (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) | Plasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 |